
The policy is a drug-compounding framework, not a supplement pathway, but it changes the regulatory backdrop for peptide products, drug preclusion arguments, and gray-market competition.
Cantox Health Sciences International, a scientific, toxicology, and regulatory consulting firm, will host the one-day symposium on November 2 in Arlington, VA.
Cantox Health Sciences International, a scientific, toxicology, and regulatory consulting firm, will host a one-day symposium on November 2 in Arlington, VA, focusing on structure/function claims.
Topics the symposium will address include:
Attendess will hear firsthand from FDA and FTC representatives: Richard Cleland, Esq., assistant director, division of advertising practices, FTC; and Daniel Fabricant, PhD, director, division of dietary supplement programs, FDA. Cantox consultants will also share their expertise.






